DRKS00029414尚未招募不适用
Determination of the SARS-CoV-2/COVID-19 seroprevalence of patients in emergency rooms at the university hospitals in North Rhine-Westphalia
Institut für Virologie Uniklinik Köln0 个研究点目标入组 3,000 人开始时间: 2022年7月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one(—)
- 性别
- All
入选标准
- •Age =18 years
- •- Study participants are patients in the emergency room of the university hospital
- •- According to the medical assessment, the information provided and the additional blood collection do not represent any additional burden for the study participants.
- •- Ability to consent and consent to participate in the study.
- •- The ability to consent is checked according to a medical assessment, also with a special focus on the medication, possible pain and the exceptional emotional situation of the patient in an emergency situation and the resulting pressure situation.
排除标准
- •- <8 weeks (males) or <12 weeks (females) since last blood volume draw of =500 mL
- •- Inability to give consent
- •- Age <18 years
研究者
相似试验
进行中(未招募)
1 期
Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies after COVID-19 Booster Vaccines – The CoVVacBoost Study - The CoVVacBoost StudyCovid (Coronavirus disease)- 19 immunisationMedDRA version: 23.1Level: PTClassification code 10084457Term: COVID-19 immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2021-006172-16-ATMedical University of Graz1,200
招募中
不适用
Evaluation of SARS-CoV-2-specific Serum parameter in Blood of Patients with present post COVID (VANCOV-01)U09.9Post COVID-19 condition, unspecifiedDRKS00032918VANUDIS GmbH60
已完成
不适用
Detection of SARS-CoV-2 using a rapid antigen test and PCR depending on symptoms and hospitalization status07.1DRKS00028072KH Labor GmbH149
招募中
不适用
The diagnostics of COVID-19 to detect SARS-CoV-2-Variant B.1.1.529 using swabs of different sites of the upper airwaysU07.1COVID-19, virus identifiedDRKS00029710Fieberambulanz des Klinikum Stuttgarts31
已完成
不适用
Evaluation of SARS-CoV-2-specific Serumparameters in Blood Samples of SARS-CoV-2-seronegative Volunteers as well as former Patients with Healed, Asymptomatic, Mild or Severe COVID-19-Courses (HTXCOV-01B)07.1GU09.9GDRKS00025863Heidelberg ImmunoTherapeutics GmbH35
